LAGUNA HILLS, Calif., May 2, 2024 /PRNewswire/ — Prelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, announced the appointment of Dr. Pat Whitworth as its new Chief Medical Officer. Dr. Whitworth’s extensive clinical and research expertise…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
